🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Julie Smith‐Gagen

University of Nevada, Reno

ORCID: 0000-0001-9796-3409
Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile
2.3Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The outcome of patients with serous papillary peritoneal cancer, fallopian tube cancer, and epithelial ovarian cancer by treatment eras: 27 years data from the SEER registry

Cancer Epidemiology(2021)10.1016/j.canep.2021.102045
Top 9%
2.3DataRank
Top 9%81 citations

Elie Rassy, Jan B. Vermorken, Tarek Assi, Joseph Kattan, Stergios Boussios +2 more

Papers

Driven by 11 papers — median percentile 91. Top paper: “The outcome of patients with serous papillary peritoneal cancer, fallopian tube cancer, and epithelial ovarian cancer by treatment eras: 27 years data from the SEER registry”.

The outcome of patients with serous papillary peritoneal cancer, fallopian tube cancer, and epithelial ovarian cancer by treatment eras: 27 years data from the SEER registry

Cancer Epidemiology(2021)10.1016/j.canep.2021.102045
Top 9%
2.3DataRank
Top 9%81 citations

Elie Rassy, Jan B. Vermorken, Tarek Assi, Joseph Kattan, Stergios Boussios +2 more

Antibody-dependent cell-mediated cytotoxicity (ADCC) in familial myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

Fatigue Biomedicine Health & Behavior(2020)10.1080/21641846.2021.1876613
N/A
0DataRank · unranked
8 citations

Jennifer J.-J. Tang, Michael Guglielmo, Julie Smith‐Gagen, Lucinda Bateman, Lydia T Navarrete-Galvan +3 more

Narrative review on serous primary peritoneal carcinoma of unknown primary site: four questions to be answered

Annals of Translational Medicine(2020)10.21037/atm-20-941
N/A
0DataRank · unranked
11 citations

Tarek Assi, Stergios Boussios, Joseph Kattan, Julie Smith‐Gagen, Nicholas Pavlidis +1 more

Inclusion of family members without ME/CFS in research studies promotes discovery of biomarkers specific for ME/CFS

Work(2020)10.3233/wor-203177
N/A
0DataRank · unranked
2 citations

Alexander P. Sung, Jennifer J.-J. Tang, Michael Guglielmo, Julie Smith‐Gagen, Lucinda Bateman +3 more

Optimizing NK-92 Serial Killers: Gamma Irradiation, CD95/FasLigation, And NK Or LAK Attack Limit Cytotoxic Efficacy

Research Square(2021)10.21203/rs.3.rs-1193866/v1
N/A
0DataRank · unranked
2 citations

Michael Guglielmo, Judith Cruz Amaya, Julie Smith‐Gagen, Vincent C. Lombardi, Rebecca Merica +2 more

Optimizing NK-92 serial killers: gamma irradiation, CD95/Fas-ligation, and NK or LAK attack limit cytotoxic efficacy

Journal of Translational Medicine(2022)10.1186/s12967-022-03350-6
N/A
0DataRank · unranked
39 citations

Michael Guglielmo, Judith Cruz Amaya, Julie Smith‐Gagen, Vincent C. Lombardi, Rebecca Merica +2 more

Detection of Antibody-Dependent Cell-Mediated Cytotoxicity—Supporting Antibodies by NK-92-CD16A Cell Externalization of CD107a: Recognition of Antibody Afucosylation and Assay Optimization

Antibodies(2023)10.3390/antib12030044
N/A
0DataRank · unranked
2 citations

Bruce Walcheck, Julie Smith‐Gagen, Vincent C. Lombardi, Dorothy Hudig, Judith Cruz Amaya

Patient characteristics associated with definitive diagnosis of metastatic pancreatic cancer in those initially diagnosed with cancer of unknown primary

Molecular and Clinical Oncology(2023)10.3892/mco.2023.2697
N/A
0DataRank · unranked
1 citations

Julie Smith‐Gagen, Leslie Elliott, Minggen Lu, Larissa L. White

Detection of ADCC-Supporting Antibodies by NK-92-CD16A Cell Externalization of CD107a: Recognition of Antibody Afucosylation and Assay Optimization

Preprints.org(2023)10.20944/preprints202305.1841.v1
N/A
0DataRank · unranked
1 citations

Bruce Walcheck, Julie Smith‐Gagen, Vincent C. Lombardi, Dorothy Hudig, Judith Cruz Amaya

Natural Killer (NK) Cell Expression of CD2 as a Predictor of Serial Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)

Antibodies(2020)10.3390/antib9040054
N/A
0DataRank · unranked
11 citations

Alexander P. Sung, Michael Guglielmo, Lydia T Navarrete-Galvan, Doug Redelman, Julie Smith‐Gagen +2 more

Patient Characteristics Associated with Definitive Diagnosis of Metastatic Pancreatic Cancer in Those Initially Diagnosed with Cancer of Unknown Primary

Research Square(2023)10.21203/rs.3.rs-2833560/v1
N/A
0DataRank · unranked
0 citations

Julie Smith‐Gagen, Leslie Elliott, Minggen Lu, Larissa L. White